In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Editorial Advisory Board
Ask The Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Guidelines for Contributors
Report Store
UsernamePublicRestriction
Tags:
BioPharmaceutical Business Strategies Business Strategies

Pfizer Gets Closer to Customers

Executive Summary

Pfizer's decision to bypass UK wholesalers and go direct to pharmacies should ultimately give it better control over product discounting. Other manufacturers are watching closely, and not just in the UK.
Table

View full table

Advertisement

Related Content

In Vivo
No Cure, No Pay: The Future of Drug Marketing?
In Vivo
No Cure, No Pay: The Future of Drug Marketing?
In Vivo
CEO Interview: AstraZeneca's David Brennan
In Vivo
NicOx's Naproxcinod: Hitting the NSAID Sweet Spot?
Pink Sheet
Putting the Bully in the Bully Pulpit: The Democrats' Plan to Cut Drug Prices
In Vivo
Reinventing Pharmacy: The Price Increase for Caremark Could Be a Price Decrease for Manufacturers
In Vivo
The Acomplia Paradox: Primary Care Drug, Targeted Population
In Vivo
The Acomplia Paradox: Primary Care Drug, Targeted Population
In Vivo
German Health Care Reform: Raising the Innovation Threshold
In Vivo
German Health Care Reform: Raising the Innovation Threshold

Topics

Related Companies

Advertisement
Tags:
BioPharmaceutical Business Strategies Business Strategies
UsernamePublicRestriction

Register

IV002901

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By